Your fact-checks will appear here
A pharmaceutical CBD product used as a reference for comparing interactions with warfarin.
Cannabidiol (CBD) has documented pharmacokinetic interactions with warfarin, supported by case reports and mechanistic data linking CBD to inhibition of CYP enzymes that metabolize warfarin (notably C...
Different CBD carriers (MCT oil, grapeseed oil, ethanol tinctures) change how quickly and how much CBD enters the bloodstream, and because CBD–warfarin interactions reported in the literature are conc...
CBD products have been reported to raise warfarin activity—most often by increasing INR and thus bleeding risk—likely via inhibition of cytochrome P450 enzymes that metabolize warfarin, but the eviden...